We describe a novel, biologically distinct type of CNS embryonal tumor—ET, PLAGL—that is presumably driven by amplification and subsequent overexpression of PLAGL1 or PLAGL2, the only recurrent molecular event detected in these tumors. The gene discussed is PLAGL2; the disease is neoplasm.